ABSTRACT

COVID-19 is a zoonotic outbreak caused by the coronavirus that causes severe acute respiratory syndrome (SARS-CoV2) that has affected over 126 million people and caused around 2.7 million deaths worldwide, with Brazil confirming 36,989,373 confirmed cases and a mortality of 698,056. To this end, an integrative review of studies published between 2020 and 2023 was conducted, identifying 4 eligible studies for analysis. The average age of patients with ischemic stroke and positive COVID-19 was 69.45 years and the countries covered by the studies were the USA, Italy, and France. The results of the studies indicate that COVID-19 patients may have an increased risk of ischemic stroke compared to influenza patients. In addition, patients with ischemic stroke and COVID-19 showed greater disease severity and higher likelihood of ICU admission and need for mechanical ventilation compared to patients with ischemic stroke and influenza. The studies highlight the importance of closely monitoring COVID-19 patients to detect signs of ischemic stroke and provide adequate treatment.